Pulse Explorar nav.journalClub Debates Tendencias Investigadores

Join discussions, follow papers, and never miss your next session.

Download on theApp Store

Inicio Explorar nav.journalClub Tendencias

⌘+K

Kanaka Tatikola | Synapse

KT

Kanaka Tatikola

PARP inhibition in cancer therapy

Johnson & Johnson (United States)

About

Research focus

PARP inhibition in cancer therapy

Impact

23 pubs · 246 cites · h-index 5

Affiliations

Work Experience

Johnson & Johnson (United States)

2024 - Present

Janssen (Belgium)

2019 - 2025

Innovative Clinical Research

2025 - 2025

Johnson & Johnson (Israel)

2025 - 2025

Janssen (United States)

2018 - 2025

Publications